๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

THE IMPACT OF PATIENT COMPLIANCE ON DRUG CONCENTRATION PROFILE IN MULTIPLE DOSES

โœ Scribed by WENPING WANG; FRANCIS HUSAN; SHEIN-CHUNG CHOW


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
646 KB
Volume
15
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

โœฆ Synopsis


Physicians commonly prescribe drugs in a multiple dosage regimen for prolonged therapeutic activity. To study the effect of multiple dosing on drug concentration in blood, researchers often use deterministic models with the assumption that drugs are administered at a fixed dosage, with equal or unequal (fixed) dosing intervals. In practice, many patients do not comply with such a rigid schedule. Hence, two possible scenarios might occur: patients might not take the prescribed dosing amount, resulting in erratic dosing sizes, they might not adhere to the dosing schedule, resulting in erratic dosing times. We propose separate statistical models for these two scenarios and study their impact on blood serum/plasma concentration.

With non-compliance, some basic concepts such as steady state need new definition. We provide a rigorous formulation for the principle of superposition which enables us to generalize the concept of steady state. Applying the proposed models, we demonstrate that non-compliance causes the drug concentration time curve to exhibit an increase in fluctuation. The increase in fluctuation due to non-compliance cannot be explained with use of the classical deterministic multiple dose model.

  1. the scheduled dosing times and the actual dosing times are the same, that is, t, = T, for all n; 2. dosing interval t,+t, = z is a fixed constant;

๐Ÿ“œ SIMILAR VOLUMES


Estimation of absorption rate constant i
โœ P. Macheras; M. Symillides; C. Reppas ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 315 KB ๐Ÿ‘ 1 views

In a recent study, Chen and Pelsorl reevaluated the applicability of the half-life approach in the assessment of the relative extent of drug absorption for bioavailabilityl bioequivalence studies. This approach is based on the comparisons of the truncated areas under the curve (AUCs; that is, AUC, )